| Seth Lederman |
Seth Lederman is the founder of Ivrea Pharmaceuticals, Inc. (founded in 2005), Tonix Pharmaceuticals, Inc. (founded in 2007), Tonix Pharmaceuticals Holding Corp. (founded in 2007), and Targent Pharmaceuticals LLC (founded in 2000). Dr. Lederman is also the founder of Vela Pharmaceuticals, Inc., and Validus LLC. Dr. Lederman's current job(s) include being the Chairman & Chief Executive Officer of Starling Pharmaceuticals, Inc. (since 2011), Chairman of Krele LLC (since 2010), President & Director of Tonix Pharmaceuticals (Canada), Inc. (since 2013), and Managing Member of Lederman & Co. LLC (since 2002), L&L Technologies, Inc. (since 1996), Plumbline LLC (since 2002), and Lederman Seth Co. LLC (since 2007). Dr. Lederman's former job(s) include being the Chairman, President & Chief Executive Officer of Tamandare Explorations, Inc. (in 2011), Chairman & Chief Executive Officer of Leder Laboratories, Inc. (from 2011 to 2018), Chairman of Validus Pharmaceuticals LLC (from 2007 to 2008), Chairman of Fontus Pharmaceuticals, Inc. (from 2007 to 2008), Director of The Research Corp. of Long Island, Inc. (from 2006 to 2011), Laboratory Director at Columbia University College of Physicians & Surgeons, Director of Tonix Pharmaceuticals (Barbados) Ltd. (from 2013 to 2015), Director of Tonix Pharma Ltd. (from 2014 to 2015), Director of Tonix Pharma Holdings Ltd. (from 2014 to 2015), Director of Konanda Pharma Fund I LP (from 2007 to 2008), Associate Professor at The Trustees of Columbia University in The City of New York (from 1996 to 2017), Member of The U.S.-Japan Business Council, Inc., Managing Partner of Konanda Pharma Partners LLC (from 2007 to 2008), and Managing Partner of Konanda General Partner LLC (from 2007 to 2008). Dr. Lederman's education history includes an undergraduate degree from Princeton University (conferred in 1979) and a doctorate degree from Columbia University College of Physicians & Surgeons (conferred in 1983). |
| Bruce L. Daugherty |
Bruce L. Daugherty is currently the Executive Vice President-Research at Tonix Pharmaceuticals Holding Corp. He previously worked as the Director at Tonix Pharmaceuticals (Canada), Inc. from 2013 to 2016 and as the Director at Tonix Pharma Ltd. from 2015 to 2016. Dr. Daugherty obtained his undergraduate degree from Washington University in St. Louis, his graduate degree from Rutgers State University of New Jersey, his doctorate from Robert Wood Johnson Medical School, and his MBA from Goizueta Business School-Emory. |
| Gregory M. Sullivan |
Gregory M. Sullivan is currently the Secretary & Chief Medical Officer at Tonix Pharmaceuticals Holding Corp. He previously worked as an Assistant Professor at Columbia University Medical Center and as a Member-Institutional Review Board at The New York State Psychiatric Institute. Dr. Sullivan obtained his undergraduate degree from the University of California, Berkeley and his doctorate from Columbia University College of Physicians & Surgeons. |
| Bradley Saenger |
Bradley Saenger is currently a Director at Tonix Pharma Holdings Ltd. and the Chief Financial Officer & Treasurer at Tonix Pharmaceuticals Holding Corp. He previously worked as an Associate Director-Accounting at Vertex Pharmaceuticals, Inc. from 2011 to 2012 and as a Manager-Corporate Accounting & Consolidations at Alere, Inc. from 2007 to 2011. Mr. Saenger completed his undergraduate degree at the University of South Africa. |
| Zeil Rosenberg |
Zeil Rosenberg is currently the Executive Vice President-Medical at Tonix Pharmaceuticals Holding Corp. Prior to this, he worked as the Chief Technical Officer-Immunization at the US Agency for International Development and as the Vice President-Medical Affairs at Admera Health LLC. Dr. Rosenberg has a graduate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Stanford University, and a doctorate degree from The University of California, San Francisco. |
| Jessica Edgar Morris |
Jessica Edgar Morris is currently the Chief Operating Officer at Tonix Pharmaceuticals Holding Corp. She previously worked as a Senior Associate-Sponsor Finance Group at American Capital Ltd., Vice President at Calvert Street Capital Partners, Inc., Associate at Silicon Valley Bank, and Vice President-Investment Management at Zhongrong Group. Ms. Morris completed her undergraduate degree at the University of Virginia. |
| Margaret Smith Bell |
Margaret Smith Bell is an Independent Director at Tonix Pharmaceuticals Holding Corp. She previously worked as a Managing Director at Putnam Investments Ltd., a Portfolio Manager at Putnam Health Sciences Trust, a Vice President at abrdn Investment Management Ltd., and a Member-Overseers Board at Beth Israel Deaconess Medical Center, Inc. Bell received her undergraduate degree from Wesleyan University and her MBA from The Wharton School of the University of Pennsylvania. |
| David Lawrence Grange |
David Lawrence Grange is the founder of Osprey Global Solutions LLC, which was founded in 2009. He holds the title of President at Osprey Global Solutions LLC starting in 2011. Mr. Grange currently holds multiple positions. He is the Chairman-Governing Board at Indiana University since 2011. He is also the Vice Chairman at Pharm-Olam International Ltd. since 2017. Additionally, he serves as a Director at the Vietnam Veterans Memorial Council of Bronx, Inc., The Eshelman Foundation, Pharm-Olam International (UK) Ltd., Gettysburg Foundation, New York State For Veterans, Inc., ViaGlobal Group LLC, Society of the First Infantry Division, and is a Member of the Philanthropy Roundtable. He started his role as an Independent Director at Tonix Pharmaceuticals Holding Corp. in 2018. Mr. Grange has held former positions as well. He was the President & Chief Executive Officer at Robert R. McCormick Tribune Foundation. From 2009 to 2011, he served as the Chief Executive Officer & Director at Pharmaceutical Product Development LLC. He was also a Director at the National Strategy Forum, Inc. and The Chicago Council on Global Affairs. Furthermore, he served as a Director at Pharm-Olam Group Ltd. from 2017 to 2020 and as a National Security Analyst at Cable News Network, Inc. He was a Member of The Partnership for New Communities. Mr. Grange obtained a graduate degree from the University of Western Kentucky. |
| Richard H. Bagger |
Richard H. Bagger is currently a Director at the Chamber of Commerce of The United States of America, a Director at The Leukemia & Lymphoma Society, Inc., an Independent Director at Tonix Pharmaceuticals Holding Corp., and the Executive Director & Partner at Christie 55 Solutions LLC. He previously held positions as Chairman at the National Pharmaceutical Council, Chairman at the HealthCare Institute of New Jersey, Chairman at the Gateway Program Development Corp., and EVP-Corporate Affairs & Strategic Market Access at Celgene Corp. He also worked as Senior VP-Worldwide Public Affairs & Policy at Pfizer Inc. and Assistant General Counsel at Blue Cross & Blue Shield of New Jersey, Inc. He is a graduate of Rutgers State University of New Jersey and holds an undergraduate degree from the Woodrow Wilson School of Public & International Affairs. |
| Adeoye Y. Olukotun |
Adeoye Y. Olukotun is the founder of VIA Pharmaceuticals, Inc. (2004) and CR Strategies LLC (2000). He is currently the Chief Executive Officer & Trustee of Electrophysiology Research Foundation, and an Independent Director at Arrowhead Pharmaceuticals, Inc. (2020) and Tonix Pharmaceuticals Holding Corp. (2018). Dr. Olukotun holds a doctorate degree from Albert Einstein College of Medicine, Inc. (1973), a graduate degree from Harvard T.H. Chan School of Public Health (1983), and an undergraduate degree from UNC School of Law (1969). |
| R. Newcomb Stillwell |
Mr. R. N. Stillwell is an Independent Director at Tonix Pharmaceuticals Holding Corp. He is on the Board of Directors at Tonix Pharmaceuticals Holding Corp. and Greater Boston Chamber of Commerce. Mr. Stillwell was previously employed as a Co-Managing Partner-Boston Office by Ropes & Gray LLP, a Principal by Bain Capital Ventures LP, and a Trustee by The Hotchkiss School. He received his undergraduate degree from Princeton University and a graduate degree from Harvard Law School. |
| Jamie D. Treco |
Jamie D. Treco is currently the Lead Independent Director at Tonix Pharmaceuticals Holding Corp. since 2020. Prior to this, he was the Managing Partner at First Chicago Advisors, Inc. starting from 2009. In his former positions, Mr. Treco worked as a Principal at Citigroup, Inc. from 1996 to 2008. He also held positions as a Principal at Salomon Brothers and as a Managing Principal at Allyon Capital Partners LLC. Mr. Treco completed his undergraduate degree at Yale University in 1997. He later obtained an MBA from Stanford Graduate School of Business. |
| Carolyn E. Taylor |
Ms. Carolyn E. Taylor is an Independent Director at Tonix Pharmaceuticals Holding Corp. She is on the Board of Directors at Tonix Pharmaceuticals Holding Corp. Ms. Taylor was previously employed as a General Counsel by Strike Derivatives, Inc., an Of Counsel by Covington & Burling LLP, an Executive Vice President & General Counsel by Longitude, Inc., and an Of Counsel by Covington & Burling LLP. She received her undergraduate degree from Brown University and a graduate degree from Columbia Law School. |
